Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Połączone interwencje żywieniowe i ćwiczeniowe u kobiet z historią raka piersi

2 października 2026 zaktualizowane przez: Prof. Dr. Alejandro Martínez-Rodríguez, University of Alicante

Badanie wpływu wdrożenia strategii żywieniowo-dietetycznych oraz programu ćwiczeń na poziom fizyczny, fizjologiczny i psychologiczny u kobiet z historią raka piersi.

This study aims to evaluate the effects of a combined dietary-nutritional and physical exercise intervention on physical, physiological, and psychological outcomes in women who are breast cancer survivors. Participants will be randomly assigned to different intervention groups involving dietary modification, exercise training, or their combination, compared to a control group. The program will last 12 weeks and will include pre- and post-intervention assessments of body composition, metabolic parameters, functional capacity, and quality of life.

The primary goal is to assess improvements in physical fitness, body composition, and emotional well-being, as well as to identify potential synergistic effects of combined interventions in this population.

Przegląd badań

Status

Zakończony

Warunki

Interwencja / Leczenie

Szczegółowy opis

Breast cancer survivors often experience long-term physical and psychological side effects derived from treatment, such as fatigue, loss of muscle mass, metabolic alterations, and reduced quality of life. Lifestyle interventions involving nutrition and exercise have demonstrated significant potential to mitigate these effects and promote overall recovery.

This randomized controlled clinical trial will include adult female breast cancer survivors who have completed their primary oncological treatment. Participants will be divided into six parallel groups:

  1. Control group - no intervention.
  2. Mediterranean diet group (MD) - individualized nutritional plan based on Mediterranean dietary patterns.
  3. Strength training group (ST) - supervised resistance exercise sessions.
  4. Endurance training group (ET) - supervised aerobic exercise sessions.
  5. Combined training group (CT) - combination of strength and endurance training.
  6. Combined diet and exercise group (MD+CT) - simultaneous application of Mediterranean diet and combined training.

The intervention will last 12 weeks, during which participants in the intervention groups will attend supervised sessions and receive continuous nutritional guidance. Assessments will be performed at baseline and after 12 weeks, including anthropometric and body composition analysis, metabolic and inflammatory markers, physical fitness testing, dietary intake, and psychological well-being scales.

This study seeks to identify the most effective strategy-dietary, physical, or combined-for improving health outcomes, functionality, and emotional recovery in breast cancer survivors, contributing to the development of comprehensive post-treatment rehabilitation programs.

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

120

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Alicante
      • Elche, Alicante, Hiszpania, 03203
        • European Institute Of Exercise and Health

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

30 lat do 65 lat (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Kobieta

Opis

Inclusion Criteria:

  • Women aged 30 to 65 years.
  • Previous diagnosis of breast cancer (stages I-III) confirmed by medical records.
  • Completion of primary oncological treatment (surgery, radiotherapy, chemotherapy, and/or hormone therapy) at least 3 months before enrollment.
  • Absence of active cancer or evidence of recurrence.
  • Medical clearance to perform physical exercise.
  • Willingness to participate in dietary and/or exercise interventions for 12 weeks.
  • Ability to attend evaluation and intervention sessions and comply with study procedures.
  • Signed written informed consent.

Exclusion Criteria:

  • Active cancer, metastasis, or ongoing chemotherapy or radiotherapy.
  • Severe cardiovascular, respiratory, renal, hepatic, or metabolic disease that contraindicates exercise.
  • Musculoskeletal or neurological conditions limiting participation in physical activity.
  • Severe psychiatric disorders or cognitive impairment affecting adherence to the intervention.
  • Current participation in another clinical trial or structured lifestyle intervention.
  • Use of dietary supplements, appetite regulators, or pharmacological agents affecting metabolism during the study period.
  • Pregnancy, breastfeeding, or intention to become pregnant during the study.
  • Inability to comply with the intervention schedule or follow-up assessments.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Brak interwencji: Arm 1 - Control Group

Participants will not receive any specific dietary or exercise intervention. They will be asked to maintain their usual lifestyle and dietary habits during the 12-week study period. General health recommendations based on national guidelines will be provided at baseline.

Eksperymentalny: Arm 2 - Mediterranean Diet Group (MD)

Participants will receive individualized nutritional counseling promoting adherence to a Mediterranean dietary pattern, emphasizing fruits, vegetables, legumes, whole grains, olive oil, nuts, fish, and moderate dairy intake. Processed and high-sugar foods will be limited. Dietitians will provide personalized follow-up and adjustments every two weeks to ensure adherence.

Individualized nutritional counseling based on Mediterranean diet principles, emphasizing the intake of fruits, vegetables, legumes, whole grains, nuts, olive oil, and fish, while reducing red meat, processed foods, and added sugars. Sessions will be held biweekly to ensure adherence and promote long-term dietary behavior change.

Eksperymentalny: Arm 3 - Strength Training Group (ST)

Participants will perform a 12-week supervised resistance training program focused on improving muscular strength and functional capacity. Sessions will be conducted three times per week, lasting approximately 60 minutes, and include major muscle groups using elastic bands, free weights, and bodyweight exercises. Training load will progressively increase according to individual capacity.

A structured resistance exercise program performed three times per week for 12 weeks. Each 60-minute session will include exercises for major muscle groups using elastic bands, dumbbells, or body weight, progressively increasing intensity to improve muscle strength and endurance.

Eksperymentalny: Arm 4 - Endurance Training Group (ET)

Participants will follow a structured aerobic exercise program consisting of walking, cycling, or treadmill sessions three times per week for 12 weeks. The intensity will be moderate (60-75% of estimated maximal heart rate), gradually progressing as tolerated. The goal is to enhance cardiorespiratory fitness and overall endurance.

A structured aerobic exercise program consisting of walking, cycling, or treadmill training three times per week for 12 weeks. Exercise intensity will range from 60% to 75% of the estimated maximal heart rate, progressively adjusted to enhance cardiovascular fitness and fatigue resistance.

Eksperymentalny: Arm 5 - Combined Training Group (CT)

Participants will perform both strength and aerobic training during the 12-week intervention. Each session (3 per week, 60-70 minutes) will include resistance exercises targeting major muscle groups followed by aerobic activity at moderate intensity. The program aims to improve both muscular and cardiovascular performance synergistically.

A combined exercise protocol including both resistance and aerobic components within each 60-70-minute session, three times per week for 12 weeks. Strength exercises will precede moderate-intensity aerobic work to improve overall physical performance and functional capacity.

Eksperymentalny: Arm 6 - Mediterranean Diet plus Combined Training Group (MD+CT)

Participants will simultaneously receive the Mediterranean Diet counseling and participate in the Combined Training program for 12 weeks. The objective is to assess the synergistic effects of diet and exercise on physical, physiological, and psychological health in breast cancer survivors.

Comprehensive lifestyle intervention combining Mediterranean diet counseling with the supervised combined training program. Participants will receive individualized diet plans and attend three supervised exercise sessions per week. The intervention targets improvements in body composition, physical fitness, and emotional well-being.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Change in Fat-Free Mass (kg)
Ramy czasowe: Baseline and Week 12

To evaluate changes in fat-free mass after the 12-week intervention, measured by bioimpedance analysis (BIODY XPERT ZM).

Baseline and Week 12

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Change in Fat Mass (%)
Ramy czasowe: Baseline and Week 12

To assess changes in total body fat percentage using bioimpedance analysis.

Baseline and Week 12
Change in Body Weight (kg)
Ramy czasowe: Baseline and Week 12

To determine body weight variation during the 12-week intervention.

Baseline and Week 12
Change in Body Mass Index (kg/m²)
Ramy czasowe: Baseline and Week 12

To evaluate changes in BMI calculated as weight divided by height squared.

Baseline and Week 12
Change in Waist Circumference (cm)
Ramy czasowe: Baseline and Week 12

To assess central adiposity changes by measuring waist circumference.

Baseline and Week 12
Change in Handgrip Strength (kg)
Ramy czasowe: Baseline and Week 12

To evaluate upper-body muscular strength using a digital hand dynamometer.

Baseline and Week 12
Change in Lower-Limb Strength (kg)
Ramy czasowe: Baseline and Week 12

To assess lower-limb strength through isometric tests using a load cell or force platform.

Baseline and Week 12
Change in Functional Capacity (6-Minute Walk Test Distance, m)
Ramy czasowe: Baseline and Week 12

To evaluate cardiorespiratory endurance using the 6-minute walk test.

Baseline and Week 12
Change in Balance Performance
Ramy czasowe: Baseline and Week 12

To assess dynamic balance and postural control

Baseline and Week 12
Change in Flexibility (Sit-and-Reach Test, cm)
Ramy czasowe: Baseline and Week 12

To evaluate flexibility of the posterior chain through the sit-and-reach test.

Baseline and Week 12
Change in Maximal Oxygen Uptake (VO₂max, mL/kg/min)
Ramy czasowe: Baseline and Week 12

To determine changes in aerobic capacity using an incremental treadmill test with indirect calorimetry (METALYZ-ERR 3 B-R3 spirometer).

Baseline and Week 12
Change in Total Cholesterol (mg/dL)
Ramy czasowe: Baseline and Week 12

To evaluate lipid profile variations by measuring total cholesterol concentration.

Baseline and Week 12
Change in HDL Cholesterol (mg/dL)
Ramy czasowe: Baseline and Week 12

To assess cardioprotective lipid changes.

Baseline and Week 12
Change in LDL Cholesterol (mg/dL)
Ramy czasowe: Baseline and Week 12

To measure changes in LDL cholesterol levels.

Baseline and Week 12
Change in Triglycerides (mg/dL)
Ramy czasowe: Baseline and Week 12

To determine variations in triglyceride concentration.

Baseline and Week 12
Change in Fasting Glucose (mg/dL)
Ramy czasowe: Baseline and Week 12

To assess metabolic health by measuring fasting plasma glucose.

Baseline and Week 12
Change in C-Reactive Protein (mg/L)
Ramy czasowe: Baseline and Week 12

To evaluate systemic inflammation using CRP levels.

Baseline and Week 12
Change in Interleukin-6 (pg/mL)
Ramy czasowe: Baseline and Week 12

To measure inflammatory status via IL-6 concentration.

Baseline and Week 12
Change in Fatigue (FACIT-F Questionnaire Score)
Ramy czasowe: Baseline and Week 12

Description: Fatigue will be assessed using the Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-F). This questionnaire consists of 13 items rated on a 5-point Likert scale ranging from 0 ("not at all") to 4 ("very much"), reflecting fatigue experienced during the past 7 days. The total score is calculated by summing the item scores (after reverse scoring where applicable). Range: 0-52. Interpretation: Higher scores indicate less fatigue and therefore a better functional status, while lower scores reflect greater fatigue severity.

Baseline and Week 12
Change in Sleep Quality (PSQI Total Score)
Ramy czasowe: Baseline and Week 12

Description: Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI), a 19-item self-reported questionnaire that evaluates sleep quality and disturbances over the previous month. The items are grouped into seven components (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction), each scored from 0 to 3. The global PSQI score is the sum of the components (range 0-21). Range: 0-21. Interpretation: Higher scores indicate poorer sleep quality.

Baseline and Week 12
Change in Physical Activity Level (IPAQ Total Score)
Ramy czasowe: Baseline and Week 12

Description: Physical activity levels will be evaluated using the International Physical Activity Questionnaire - Short Form (IPAQ-SF), which records the frequency and duration of walking, moderate, and vigorous activities over the past 7 days. The results are expressed as total metabolic equivalent minutes per week (MET-min/week) and can be categorized into three levels: low, moderate, or high activity. Range: 0 to unlimited MET-min/week. Interpretation: Higher scores indicate higher physical activity levels.

Baseline and Week 12
Change in Dietary Adherence (Mediterranean Diet Adherence Screener Score)
Ramy czasowe: Baseline and Week 12

Description: Adherence to the Mediterranean diet will be assessed using the PREDIMED Questionnaire, a validated 14-item questionnaire evaluating key dietary habits such as olive oil use, fruit and vegetable consumption, fish intake, and limitation of red meat and sweets. Each affirmative answer scores 1 point, yielding a total score from 0 (minimal adherence) to 14 (maximal adherence). Range: 0-14. Interpretation: Higher scores indicate better adherence to the Mediterranean dietary pattern.

Baseline and Week 12

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

1 września 2023

Zakończenie podstawowe (Rzeczywisty)

31 grudnia 2025

Ukończenie studiów (Rzeczywisty)

30 czerwca 2026

Daty rejestracji na studia

Pierwszy przesłany

25 listopada 2025

Pierwszy przesłany, który spełnia kryteria kontroli jakości

8 grudnia 2025

Pierwszy wysłany (Rzeczywisty)

10 grudnia 2025

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

5 października 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

2 października 2026

Ostatnia weryfikacja

1 lutego 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • UA-2025-06-13

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .